SAN DIEGO, Feb. 24, 2011 /- Gen-Probe Incorporated (Nasdaq: GPRO ) announced today that the Company will present at three upcoming investor conferences: RBC Capital Markets' Healthcare Conference in New York at 10 a.m. Eastern Time (ET) on March 2. The Company also will participate...

(European Society for Medical Oncology) A drug that is currently used to help treat bone metastases in patients with lung cancer could also be useful at an earlier stage of treatment, to prevent the cancer from spreading in the first place, Italian researchers have found.

(European Society for Medical Oncology) An inexpensive and rapid testing method can effectively identify a sub-group of never-smoking lung cancer patients whose tumors express a molecule associated with increased risk of disease progression or recurrence, US researchers have found

The Institute of Microelectronics (IME), a research institute of the Agency for Science, Technology and Research (A*STAR), today announced that it has developed and successfully demonstrated an Ultra-Wideband (UWB) radio for use in Pirelli?s Cyber? Tyre.

Printer maker Lexmark International Inc. said Thursday its board
of directors elected the company's chief executive, Paul Rooke, as
its next chairman. He replaces retiring executive chairman Paul
Curlander.Curlander was Lexmark's CEO from 1998 to 2010. He has
worked for the company since 1991,...

Health-care information technology company SXC Health Solutions Corp. (TSX:SXC) reports fourth-quarter profit of US$16.6 million or 26 cents per share, up from year-earlier net income of $15.2 million or 24 cents. Quarterly revenue rose to US$526.9 million from $443.3 million

(Deutsches Aerzteblatt International) Infections are among the most frequent complications of a stay in hospital and raise the complication and mortality rates. Calculations based on data from the Hospital Infection Surveillance System showed an incidence of almost 60 000 newly...

(International Osteoporosis Foundation) An audit report by the International Osteoporosis Foundation consolidates information on the status and burden of osteoporosis in 21 countries of Eastern Europe and Central Asia, including the Russian Federation. The publication includes...

NEW HAVEN, Conn., Feb. 24, 2011 /- Mira Dx announced today that it has licensed technology from Yale University based on the acceptance of a pivotal breast cancer study in the January issue of the journal Cell Cycle . While numerous BRCA1 coding sequence mutations are associated with...